HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

‘Acquisitive and Entrepreneurial’ Stada Spies Further M&A Opportunities In US And Elsewhere

Stada Arzneimittel is looking for local partners and/or acquisition opportunities in the US to expand its offer and quickly establish its presence in the country, Stada executive vice president Roger Scarlett-Smith tells HBW Insight in this exclusive interview.

International Health

EU Business Round-Up: Mayoly Spindler Acquires Biohealth, Flarin Gets Funding, Karo Ready For M&A

The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.

Deals Business Strategies

Consumer Health Business News: Rebrands for Takeda OTC And Reckitt, DSM Acquires, Enzymatica Raises Funds

A round-up of the latest consumer health industry news: Takeda completes the sale of its Japanese OTC business, which has rebranded as Alinamin; Reckitt drops the "Benckiser" from its name to signal new approach; Enzymatica looks to raise funds as COVID continues to bite; and Royal DSM expands its portfolio through a new deal with Amyris. 

Asia Pacific Europe
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

Stronger Brand Sales Among Shifts In US Consumer Health Market Trends During Pandemic – IRI

US consumer health sales jumped 6.7% in 2020 in stores, a reversal of recent years as consumers move away from private label, “on-the-go” and natural oral care during the pandemic, IRI data show.

Market Intelligence Retail

‘Acquisitive and Entrepreneurial’ Stada Spies Further M&A Opportunities In US And Elsewhere

Stada Arzneimittel is looking for local partners and/or acquisition opportunities in the US to expand its offer and quickly establish its presence in the country, Stada executive vice president Roger Scarlett-Smith tells HBW Insight in this exclusive interview.

International Health

Alibaba's Unprecedented $2.8bn Fine Could Signal Start Of Antitrust Wave In China

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. Past cases show the pharma sector is not immune and while it remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions. 

E-Commerce Enforcement
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Primatene Mist Reaches Target Stores, Amphastar Spends Behind Reaching $65M Sales Target

In addition to distributing to Target stores, TV, radio and digital advertising and late-2020 start of sales at Kroger stores are driving Primatene Mist sales growth. The epinephrine aerosol inhaler's sales increased 186% in 2020 to $51.7m and 47% in Q4 to $13.4m.

OTC Drugs Sales & Earnings

Stada Makes US Consumer Health Play After Strong Gains In Europe

Stada has entered the US dietary supplements category following significant gains for its Branded Products business in 2020. Acquisitions helped to drive up Branded Products sales by 27% last year, enabling Stada to become a top-five player in Europe's consumer health market. 

Sales & Earnings Launches

EU Business Round-Up: Bionorica's Sales Hit By COVID, Precision Takes Kwai To Austria, Alfasigma Hires Italy Chief

The latest European consumer health news: Germany's Bionorica posts double-digit sales decline due to COVID; Precision Healthcare takes Kwai to Austria; and Alfasigma hires Janssen exec to lead expanded Italy business.

Europe Business Strategies
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

Alibaba's Unprecedented $2.8bn Fine Could Signal Start Of Antitrust Wave In China

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. Past cases show the pharma sector is not immune and while it remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions. 

E-Commerce Enforcement

50 Years After Pioneering Vaginal Care Branding, Combe Fends Off Similar Competing Trademark

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Legal Issues OTC Drugs

Crest Charcoal Toothpaste Claims Mislead Consumers – Class Action Complaint

“In recent years, health and beauty products containing activated charcoal have become a consumer sensation,” and P&G/Crest has sought to capitalize on demand with falsely advertised charcoal toothpaste offerings, according to plaintiff Belinda Housey’s class action complaint in New York’s Southern District.

United States Legal Issues
See All
UsernamePublicRestriction

Register